Geode Capital Management’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-167,216
| Closed | -$496K | – | 4090 |
|
2016
Q3 | $496K | Buy |
167,216
+77
| +0% | +$228 | ﹤0.01% | 3251 |
|
2016
Q2 | $249K | Sell |
167,139
-54,545
| -25% | -$81.3K | ﹤0.01% | 3504 |
|
2016
Q1 | $819 | Buy |
221,684
+46,552
| +27% | +$172 | ﹤0.01% | 2993 |
|
2015
Q4 | $1.77M | Buy |
175,132
+1,477
| +0.9% | +$14.9K | ﹤0.01% | 2560 |
|
2015
Q3 | $2.36M | Buy |
173,655
+7,109
| +4% | +$96.7K | ﹤0.01% | 2339 |
|
2015
Q2 | $3.16M | Sell |
166,546
-1,021
| -0.6% | -$19.4K | ﹤0.01% | 2215 |
|
2015
Q1 | $4.39M | Buy |
167,567
+13,179
| +9% | +$345K | ﹤0.01% | 1933 |
|
2014
Q4 | $3.23M | Sell |
154,388
-990
| -0.6% | -$20.7K | ﹤0.01% | 2103 |
|
2014
Q3 | $5.19M | Buy |
155,378
+9,958
| +7% | +$332K | ﹤0.01% | 1747 |
|
2014
Q2 | $4.67M | Buy |
145,420
+5,180
| +4% | +$166K | ﹤0.01% | 1832 |
|
2014
Q1 | $6.47M | Buy |
140,240
+11,188
| +9% | +$516K | ﹤0.01% | 1581 |
|
2013
Q4 | $9.16M | Sell |
129,052
-3,858
| -3% | -$274K | 0.01% | 1245 |
|
2013
Q3 | $11.4M | Buy |
132,910
+56,207
| +73% | +$4.82M | 0.01% | 978 |
|
2013
Q2 | $4.86M | Buy |
+76,703
| New | +$4.86M | ﹤0.01% | 1435 |
|